Ginkgo Bioworks Holdings Inc
General ticker "DNA" information:
- Sector: Materials
- Industry: Chemicals
- Capitalization: $496.7M
Ginkgo Bioworks Holdings Inc does not follow the US Stock Market performance with the rate: -29.0%.
Estimated limits based on current volatility of 8.2%: low 8.23$, high 9.69$
Factors to consider:
- Current price 65.8% below estimated low
- Earnings for 9 months up through Q3 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [29.44$, 73.23$]
- 2024-12-30 to 2025-12-30 estimated range: [23.44$, 57.97$]
Financial Metrics affecting the DNA estimates:
- Negative: Non-GAAP EPS, $ of -0.35 <= 0.10
- Negative: Operating profit margin, % of -77.47 <= 1.03
- Negative: Operating cash flow per share per price, % of -9.24 <= 2.35
- Positive: 2.14 < Industry operating profit margin (median), % of 6.58
- Positive: Interest expense per share, $ of 0 <= 0.14
- Negative: negative Net income
Short-term DNA quotes
Long-term DNA plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $313.84MM | $477.71MM | $251.46MM |
| Operating Expenses | $2,142.30MM | $2,686.66MM | $1,115.86MM |
| Operating Income | $-1,828.47MM | $-2,208.95MM | $-864.41MM |
| Non-Operating Income | $-9.65MM | $87.55MM | $-28.53MM |
| Interest Expense | $2.37MM | $0.11MM | $0.09MM |
| R&D Expense | $1,149.66MM | $1,052.64MM | $580.62MM |
| Income(Loss) | $-1,838.12MM | $-2,121.40MM | $-892.94MM |
| Taxes | $-1.48MM | $-15.03MM | $-0.07MM |
| Profit(Loss) | $-1,836.64MM | $-2,106.37MM | $-892.87MM |
| Stockholders Equity | $1,505.37MM | $1,736.28MM | $1,097.15MM |
| Inventory | $3.36MM | $4.36MM | $0.05MM |
| Assets | $2,070.99MM | $2,539.32MM | $1,665.34MM |
| Operating Cash Flow | $-253.82MM | $-252.20MM | $-295.50MM |
| Capital expenditure | $56.52MM | $52.27MM | $40.80MM |
| Investing Cash Flow | $-73.26MM | $-67.39MM | $-80.69MM |
| Financing Cash Flow | $1,534.14MM | $95.34MM | $-3.22MM |
| Earnings Per Share* | $-53.83 | $-50.15 | $-18.37 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.